Michael J. de la Merced / New York Times:

Isomorphic Labs, a DeepMind spinoff focusing on drug discovery, raised $600M led by Thrive to research treatments, including for cancer and immune disorders  —  The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital as a backer.

Michael J. de la Merced / New York Times:

Isomorphic Labs, a DeepMind spinoff focusing on drug discovery, raised $600M led by Thrive to research treatments, including for cancer and immune disorders  —  The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital as a backer.

Source: TechMeme
Source Link: http://www.techmeme.com/250331/p18#a250331p18